Results 1 to 10 of about 205 (151)

Screening of cytoprotectors against methotrexate-induced cytogenotoxicity from bioactive phytochemicals [PDF]

open access: yesPeerJ, 2016
As a well known anti-neoplastic drug, the cytogenotoxicity of methotrexate (MTX) has received more attention in recent years. To develop a new cytoprotector to reduce the risk of second cancers caused by methotrexate, an umu test combined with a ...
Shaobin Gu, Ying Wu, Jianbo Yang
doaj   +5 more sources

Cytoprotective Activity of Newly Synthesized 3-(Arylmethylamino)-6-Methyl-4-Phenylpyridin-2(1H)-Ones Derivatives [PDF]

open access: yesMolecules, 2022
Currently, studies are being conducted on the possible role of the cytoprotective effect of biologically active substances in conditions of cerebral hypoxia or cardiomyopathies.
Shynggys Sergazy   +5 more
doaj   +2 more sources

Heme-Oxygenase 1 Mediated Activation of Cyp3A11 Protects Against Non-Steroidal Pain Analgesics Induced Acute Liver Damage in Sickle Cell Disease Mice [PDF]

open access: yesCells
Pain constitutes a significant comorbidity associated with sickle cell disease (SCD). Analgesics serve as the primary method for pain management; however, the long-term effects of these drugs on the liver of SCD patients remain not completely understood.
Ravi Vats   +4 more
doaj   +2 more sources

In vitro study of the anticancer activity of various doxorubicin-containing dispersions [PDF]

open access: yesBioImpacts, 2019
Introduction: The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids, e.g. singlewalled carbon nanotube (SWCNT)+Dox, graphene oxide (GO)+Dox and DextranPNIPAM (copolymer)+Dox mixtures on HeLa cells (human ...
Tatiana Matvienko   +9 more
doaj   +2 more sources

Coal-Derived Humic Substances: Insight into Chemical Structure Parameters and Biomedical Properties [PDF]

open access: yesMolecules
An investigation was carried out on humic substances (HSs) isolated from the coal of the Kansk-Achinsk basin (Krasnoyarsk Territory, Russia). The coal HSs demonstrate the main parameters of molecular structure inherent to this class of natural compounds.
Maria V. Zykova   +16 more
doaj   +2 more sources

Regulatory Role and Cytoprotective Effects of Exogenous Recombinant SELENOM under Ischemia-like Conditions and Glutamate Excitotoxicity in Cortical Cells In Vitro [PDF]

open access: yesBiomedicines
Despite the successes in the prevention and treatment of strokes, it is still necessary to search for effective cytoprotectors that can suppress the damaging factors of cerebral ischemia.
Egor A. Turovsky   +2 more
doaj   +2 more sources

Efficacy of a cytoprotector mexicor in urgent cardiology

open access: yesТерапевтический архив, 2004
Aim. To study efficacy of cytoprotector mexicor in patients with unstable angina (UA), acute myocardial infarction (MI), hypertensive crises (HC) in combined therapy with conventional drugs. Material and methods.
A P Golikov   +8 more
doaj   +1 more source

Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application [PDF]

open access: yesPharmaceuticals
Dehydroepiandrosterone and its sulfate are the most abundant steroids in humans. The metabolism of dehydroepiandrosterone can differ significantly depending on the organ or tissue and the subtype of steroid receptors expressed in it.
Tatiana A. Fedotcheva   +3 more
doaj   +2 more sources

CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL

open access: yesРоссийский кардиологический журнал, 2009
The study investigated the effects of cardiac cytoprotectors – mildronate and trimetazidine, combined with ACE therapy, on lipid peroxidation product levels, endothelial function, circadian blood pressure (BP) profile, left ventricular myocardium, and ...
F. E. Khebodarov, V. P. Mikhin
doaj   +1 more source

INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS

open access: yesРациональная фармакотерапия в кардиологии, 2015
Indications for myocardial cytoprotector, trimetazidine, in patients with ischemic heart disease are analyzed and justified according to evidence based medicine.
Zh. M. Sizova
doaj   +5 more sources

Home - About - Disclaimer - Privacy